These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 3498533

  • 41. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC, Schmid FA, Feinberg A, Philips FS, Han J.
    Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
    [Abstract] [Full Text] [Related]

  • 42. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
    Spinella MJ, Brigle KE, Sierra EE, Goldman ID.
    J Biol Chem; 1995 Apr 07; 270(14):7842-9. PubMed ID: 7713875
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of DNA synthesis and enhancement of the uptake and action of methotrexate by low-power-density microwave radiation in L1210 leukemia cells.
    Chang BK, Huang AT, Joines WT.
    Cancer Res; 1980 Apr 07; 40(4):1002-5. PubMed ID: 7357530
    [Abstract] [Full Text] [Related]

  • 44. Kinetic correlates of methotrexate transport and therapeutic responsiveness in murine tumors.
    Sirotnak FM, Donsbach RC.
    Cancer Res; 1976 Mar 07; 36(3):1151-8. PubMed ID: 943237
    [Abstract] [Full Text] [Related]

  • 45. Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: effect of inhibitors of equilibrative systems on the content and retention of nucleosides.
    Dagnino L, Paterson AR.
    Cancer Res; 1990 Oct 15; 50(20):6549-53. PubMed ID: 1698538
    [Abstract] [Full Text] [Related]

  • 46. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.
    Jansen G, Westerhof GR, Jarmuszewski MJ, Kathmann I, Rijksen G, Schornagel JH.
    J Biol Chem; 1990 Oct 25; 265(30):18272-7. PubMed ID: 2211701
    [Abstract] [Full Text] [Related]

  • 47. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression.
    Breier A, Stefanková Z, Barancík M, Tribulová N.
    Gen Physiol Biophys; 1994 Aug 25; 13(4):287-98. PubMed ID: 7890145
    [Abstract] [Full Text] [Related]

  • 48. [Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
    Goncharova SA, Frankfurt OS.
    Tsitologiia; 1975 Sep 25; 17(9):1051-6. PubMed ID: 1166521
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Comparison of transport properties of the reduced folate carrier and folate receptor in murine L1210 leukemia cells.
    Sierra EE, Brigle KE, Spinella MJ, Goldman ID.
    Biochem Pharmacol; 1995 Oct 12; 50(8):1287-94. PubMed ID: 7488246
    [Abstract] [Full Text] [Related]

  • 53. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
    Sierra EE, Brigle KE, Spinella MJ, Goldman ID.
    Biochem Pharmacol; 1997 Jan 24; 53(2):223-31. PubMed ID: 9037255
    [Abstract] [Full Text] [Related]

  • 54. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
    Jansen G, van der Heijden J, Oerlemans R, Lems WF, Ifergan I, Scheper RJ, Assaraf YG, Dijkmans BA.
    Arthritis Rheum; 2004 Jul 24; 50(7):2130-9. PubMed ID: 15248210
    [Abstract] [Full Text] [Related]

  • 55. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
    Jackman AL, Kimbell R, Aherne GW, Brunton L, Jansen G, Stephens TC, Smith MN, Wardleworth JM, Boyle FT.
    Clin Cancer Res; 1997 Jun 24; 3(6):911-21. PubMed ID: 9815766
    [Abstract] [Full Text] [Related]

  • 56. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K, Blechman WJ, Riddle VG, Pardee AB.
    Cancer Res; 1981 Nov 24; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [Abstract] [Full Text] [Related]

  • 57. Membrane transport of methotrexate in a squamous carcinoma cell line adapted to low folate concentrations.
    van der Laan BF, Jansen G, van Gestel JA, Schornagel JH, Hordijk GJ.
    Anticancer Res; 1991 Nov 24; 11(3):1265-8. PubMed ID: 1888158
    [Abstract] [Full Text] [Related]

  • 58. The effects on 4-aminoantifolates on 5-formyltetrahydrofolate metabolism in L1210 cells. A biochemical basis of the selectivity of leucovorin rescue.
    Matherly LH, Barlowe CK, Phillips VM, Goldman ID.
    J Biol Chem; 1987 Jan 15; 262(2):710-7. PubMed ID: 2948949
    [Abstract] [Full Text] [Related]

  • 59. A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues. Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells.
    Roy K, Tolner B, Chiao JH, Sirotnak FM.
    J Biol Chem; 1998 Jan 30; 273(5):2526-31. PubMed ID: 9446553
    [Abstract] [Full Text] [Related]

  • 60. Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.
    Duch DS, Banks S, Dev IK, Dickerson SH, Ferone R, Heath LS, Humphreys J, Knick V, Pendergast W, Singer S.
    Cancer Res; 1993 Feb 15; 53(4):810-8. PubMed ID: 8428362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.